{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:53:18Z","timestamp":1776945198700,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,24]]},"DOI":"10.7759\/cureus.65295","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:45:58Z","timestamp":1721853958000},"source":"Crossref","is-referenced-by-count":1,"title":["Oculogyric Crisis Following Dosage Increase of Aripiprazole: A Case Report"],"prefix":"10.7759","author":[{"given":"Nikhale","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorv","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmita","family":"Mantravadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Kambhatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7916\/D85X2N2D","article-title":"Oculogyric crises","volume":"7","author":"Solberg M","year":"2017","unstructured":"Solberg M, Koht J. Oculogyric crises. Tremor Other Hyperkinet Mov (N Y). 2017, 7:491. 10.7916\/D85X2N2D","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.11.012","article-title":"Oculogyric crises: etiology, pathophysiology and therapeutic approaches","volume":"36","author":"Barow E","year":"2017","unstructured":"Barow E, Schneider SA, Bhatia KP, Ganos C. Oculogyric crises: etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord. 2017, 36:3-9. 10.1016\/j.parkreldis.2016.11.012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2004.10.004","article-title":"Neuroleptic-induced movement disorders: an overview","volume":"28","author":"Sachdev PS","year":"2005","unstructured":"Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am. 2005, 28:255-74. 10.1016\/j.psc.2004.10.004","journal-title":"Psychiatr Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-34044-1.00016-X","article-title":"Eye movement disorders: conjugate gaze abnormalities","author":"Gold DR","year":"2019","unstructured":"Gold DR. Eye movement disorders: conjugate gaze abnormalities. Liu, Volpe, and Galetta\u2019s Neuro-Ophthalmology: Diagnosis and Management, 3rd Edition. Liu GT, Volpe NJ, Galetta SL (ed): Elsevier, Amsterdam, Netherlands; 2019. 549-84. 10.1016\/B978-0-323-34044-1.00016-X"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26910","article-title":"Oculogyric crises: a review of phenomenology, etiology, pathogenesis, and treatment","volume":"32","author":"Slow EJ","year":"2017","unstructured":"Slow EJ, Lang AE. Oculogyric crises: a review of phenomenology, etiology, pathogenesis, and treatment. Mov Disord. 2017, 32:193-202. 10.1002\/mds.26910","journal-title":"Mov Disord"},{"key":"ref6","article-title":"Aripiprazole","author":"Gettu N","year":"2024","unstructured":"Gettu N, Saadabadi A. Aripiprazole. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.encep.2018.10.003","article-title":"Aripiprazole as dopamine partial agonist model: basic concepts and clinical impact. (Article in French)","volume":"44","author":"Simon N","year":"2018","unstructured":"Simon N, Azorin JM. Aripiprazole as dopamine partial agonist model: basic concepts and clinical impact. (Article in French). Encephale. 2018, 44:558-64. 10.1016\/j.encep.2018.10.003","journal-title":"Encephale"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709009948","article-title":"Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects","volume":"12","author":"Han M","year":"2009","unstructured":"Han M, Huang XF, Deng C. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. Int J Neuropsychopharmacol. 2009, 12:941-52. 10.1017\/S1461145709009948","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1503\/jpn.210026","article-title":"Oculogyric crisis: a rare type of dystonia","volume":"46","author":"Boi S","year":"2021","unstructured":"Boi S, Garcia-Malo C, Rodr\u00edguez CI. Oculogyric crisis: a rare type of dystonia. J Psychiatry Neurosci. 2021, 46:E429-30. 10.1503\/jpn.210026","journal-title":"J Psychiatry Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27217","article-title":"Oculogyric crisis in the setting of low dose risperidone and benztropine mesylate use in a patient with schizophrenia: a case report and review of literature","volume":"14","author":"Ruiz de Villa A","year":"2022","unstructured":"Ruiz de Villa A, Haider AA, Frimer L, Bazikian Y. Oculogyric crisis in the setting of low dose risperidone and benztropine mesylate use in a patient with schizophrenia: a case report and review of literature. Cureus. 2022, 14:e27217. 10.7759\/cureus.27217","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0253717620942096","article-title":"Spotlight on oculogyric crisis: a review","volume":"43","author":"Mahal P","year":"2021","unstructured":"Mahal P, Suthar N, Nebhinani N. Spotlight on oculogyric crisis: a review. Indian J Psychol Med. 2021, 43:5-9. 10.1177\/0253717620942096","journal-title":"Indian J Psychol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/350417","article-title":"Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine","volume":"2011","author":"Peterson AL","year":"2011","unstructured":"Peterson AL, Seegmiller RA, Schindler LS. Severe neuropsychiatric reaction in a deployed military member after prophylactic mefloquine. Case Rep Psychiatry. 2011, 2011:350417. 10.1155\/2011\/350417","journal-title":"Case Rep Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/273741-oculogyric-crisis-following-dosage-increase-of-aripiprazole-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:46:04Z","timestamp":1721853964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/273741-oculogyric-crisis-following-dosage-increase-of-aripiprazole-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.65295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}